\-\ Texto\\:\\ \ \(0\)\
\-\ palpable\\ left\\ axillary\\ adenopathy\\.\ \(0\)\
\-\ asymmetric\\ skin\\ and\\ trabecular\\ thickening\\ and\\ a\\ solid\\ mass\\ at\\ the\\ 6\\:00\\ position\\ of\\ the\\ affected\\ breast\\ with\\ associated\\ axillary\\ adenopathy\\.\ \(0\)\
\-\ inflammatory\\ breast\\ carcinoma\ \(0\)\
\-\ metastatic\\ disease\\,\\ lymphoma\\,\\ mastitis\\ with\\ focal\\ phlegmonous\\ inflammation\\ \\(not\\ yet\\ an\\ abscess\\)\ \(0\)\
\-\ 48\\ yo\\ woman\\ with\\ palpable\\ abnormality\\ 5\\:00\\-6\\:00\\ position\\ of\\ left\\ breast\\ with\\ signs\\ of\\ breast\\ edema\\ on\\ recent\\ screening\\ exam\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.1882124145570479\ \(0\)\
\-\ axillary\\:\\ 0\\.1385412284797272\ \(0\)\
\-\ 5\\:00\\-6\\:00\\:\\ 0\\.13157490185024623\ \(0\)\
\-\ 6\\:00\\:\\ 0\\.11517770351191624\ \(0\)\
\-\ adenopathy\\:\\ 0\\.11357860089164902\ \(0\)\
\-\ position\\:\\ 0\\.10620964334145423\ \(0\)\
\-\ phlegmonous\\:\\ 0\\.10483222320505138\ \(0\)\
\-\ mastitis\\:\\ 0\\.09878050517358625\ \(0\)\
\-\ palpable\\:\\ 0\\.0904065982865609\ \(0\)\
\-\ trabecular\\:\\ 0\\.08238330683525626\ \(0\)\
\-\ yet\\:\\ 0\\.07149502586912461\ \(0\)\
\-\ 48\\:\\ 0\\.062399842324430785\ \(0\)\
\-\ asymmetric\\:\\ 0\\.06197133328140942\ \(0\)\
\-\ affected\\:\\ 0\\.055186934500742434\ \(0\)\
\-\ screening\\:\\ 0\\.05440349893922905\ \(0\)\
\-\ inflammation\\:\\ 0\\.05423484886081214\ \(0\)\
\-\ solid\\:\\ 0\\.05087084555979671\ \(0\)\
\-\ skin\\:\\ 0\\.04898699903341758\ \(0\)\
\-\ abnormality\\:\\ 0\\.047053103639261976\ \(0\)\
\-\ signs\\:\\ 0\\.04488620796994111\ \(0\)\
\-\ inflammatory\\:\\ 0\\.0442285961819705\ \(0\)\
\-\ thickening\\:\\ 0\\.04323320253273659\ \(0\)\
\-\ recent\\:\\ 0\\.042876403714026824\ \(0\)\
\-\ abscess\\:\\ 0\\.040325914091556225\ \(0\)\
\-\ yo\\:\\ 0\\.03837838094481734\ \(0\)\
\-\ lymphoma\\:\\ 0\\.03645072588641023\ \(0\)\
\-\ focal\\:\\ 0\\.03642527767370749\ \(0\)\
\-\ carcinoma\\:\\ 0\\.03614817417934129\ \(0\)\
\-\ edema\\:\\ 0\\.03607348491688494\ \(0\)\
\-\ metastatic\\:\\ 0\\.03210611050173269\ \(0\)\
\-\ associated\\:\\ 0\\.030096456147876146\ \(0\)\
\-\ woman\\:\\ 0\\.02946123802222248\ \(0\)\
\-\ left\\:\\ 0\\.028540455799191483\ \(0\)\
\-\ exam\\:\\ 0\\.02801841701417221\ \(0\)\
\-\ disease\\:\\ 0\\.020846828973368717\ \(0\)\
\-\ not\\:\\ 0\\.01843012942898411\ \(0\)\
\-\ mass\\:\\ 0\\.017738223984292006\ \(0\)\
\-\ an\\:\\ 0\\.01763678901917507\ \(0\)\
\-\ at\\:\\ 0\\.017280047057188552\ \(0\)\
\-\ on\\:\\ 0\\.010804343468140718\ \(0\)\
\-\ \\(\\:\\ 0\\.010781518302147172\ \(0\)\
\-\ \\)\\:\\ 0\\.010649816300198582\ \(0\)\
\-\ \\,\\:\\ 0\\.008080897478127982\ \(0\)\
\-\ with\\:\\ 0\\.006985323945665059\ \(0\)\
\-\ a\\:\\ 0\\.005919400027143302\ \(0\)\
\-\ and\\:\\ 0\\.005373403156185626\ \(0\)\
\-\ of\\:\\ 0\\.005216588095432318\ \(0\)\
\-\ the\\:\\ 0\\.004126844319511218\ \(0\)\
\-\ \\.\\:\\ 0\\.0015895314670453554\ \(0\)\
